Delivery Order SPE2DR25D1053-SPE2DR26FV248
Award Date 1/5/26
Potential Completion Date 1/27/26
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Onivyde 43 mg/10 mL vials. This firm fixed-price contract, valued at $19,596.36, represents a non-set-aside competitive award with a completion date of January 15, 2026. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on April 24, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Onivyde is a specialized oncology medication used in cancer treatment, reflecting...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for ONIVYDE 43 mg/10 ml vials, valued at $10,691.34 under a firm fixed price contract type. The award was made on September 23, 2025, with an ultimate completion date of October 15, 2025, and the work will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order draws from AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of ONIVYDE 43 mg/10 mL vials valued at $10,691.34. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The award represents a non-competitive, non-set-aside delivery order, indicating it was issued under an existing contract vehicle rather than...
- The Defense Logistics Agency awarded a $9,772.56 firm fixed price delivery order to Amerisourcebergen Drug Corp for ONIVYDE 43 MG/10 ML vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver 10 mL vials of ONIVYDE, an oncology drug, to a location in Conshohocken, Pennsylvania by August 31, 2023 to support the Department of Defense's medical programs. No set aside designation or subcontractors were identified. The delivery order was issued against an existing DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $5,345.67 and a performance period through June 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of IMFINZI 500 mg/10 mL vials, a specialty pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $39,788.55, represents a non-competitive award and is scheduled for completion by October 14, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,119.68 for 7-count bottles of Ibrance 100 mg tablets, a prescription oncology medication. This competitively awarded, firm fixed-price delivery order was issued on December 29, 2025, with an ultimate completion date of January 21, 2026. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 28, 2025, by the Defense Logistics Agency to supply 60 tablets of Tibsovo 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $43,654.80 and is scheduled for completion by October 20, 2025. The contract contains no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $11,435.46 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Yervoy 50 mg/10 ml vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA....